Serum Interleukin-34 Levels Are Elevated in Patients with Systemic Lupus Erythematosus
Interleukin-34 (IL-34) was initially identified as an alternative ligand for the colony-stimulating factor-1 receptor (CSF-1R) to mediate the biology of mononuclear phagocytic cells. Recently, IL-34 was found to be associated with chronic inflammation, such as in rheumatoid arthritis (RA). Both RA a...
Main Authors: | Hongxu Wang, Ju Cao, Xiaofei Lai |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-12-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/22/1/35 |
Similar Items
-
Current Insights and Future Prospects for Targeting IL-17 to Treat Patients With Systemic Lupus Erythematosus
by: Tomohiro Koga, et al.
Published: (2021-02-01) -
Laporan Kasus Cutaneus Discoid Lupus Erythematosus
by: Sarah Yunara, et al.
Published: (2017-01-01) -
Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus
by: Rachel Mende, et al.
Published: (2018-06-01) -
Clinical significance of serum and urinary interleukin-6 in systemic lupus erythematosus patients
by: A. Dima, et al.
Published: (2017-01-01) -
Cytokines and Inflammatory Mediators in Systemic Lupus Erythematosus
by: Manuel Rojas, et al.
Published: (2018-07-01)